PropertyValue
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/ns/prov#value
  • Takeda estimates that it is the seventh largest pharmaceutical company in Russia and expects company annual growth rate of 15% in Russia between 2012 and 2016. ???The completion of this ambitious project further demonstrates Takeda???s transition into a truly global business, and strategic investment into key emerging markets, such as Russia, is a major part of this strategy,??? said Yasuchika Has
http://www.w3.org/ns/prov#wasQuotedFrom
  • pharmtech.com